Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Spike-antibody waning after second dose of BNT162b2 or ChAdOx1
Madhumita Shrotri, Annalan M D Navaratnam, Vincent Nguyen, et al.
The Lancet (2021) Vol. 398, Iss. 10298, pp. 385-387
Open Access | Times Cited: 402

Showing 26-50 of 402 citing articles:

Two-dose ChAdOx1 nCoV-19 vaccine protection against COVID-19 hospital admissions and deaths over time: a retrospective, population-based cohort study in Scotland and Brazil
Srinivasa Vittal Katikireddi, Thiago Cerqueira‐Silva, Eleftheria Vasileiou, et al.
The Lancet (2021) Vol. 399, Iss. 10319, pp. 25-35
Open Access | Times Cited: 85
COVID-19 Vaccine Boosters: The Good, the Bad, and the Ugly
Piotr Rzymski, Carlos A. Camargo, Andrzej Fal, et al.
Vaccines (2021) Vol. 9, Iss. 11, pp. 1299-1299
Open Access | Times Cited: 76
Long-term immunogenicity of BNT162b2 vaccination in older people and younger health-care workers
Pinkus Tober‐Lau, Tatjana Schwarz, Kanika Vanshylla, et al.
The Lancet Respiratory Medicine (2021) Vol. 9, Iss. 11, pp. e104-e105
Open Access | Times Cited: 74
Correlation of SARS-CoV-2 Breakthrough Infections to Time-from-vaccine; Preliminary Study
Barak Mizrahi, Roni Lotan, Nir Kalkstein, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 73
Safety and efficacy of fluvoxamine in COVID‐19 ICU patients: An open label, prospective cohort trial with matched controls
Martina Čalušić, Robert Marčec, Lea Luksa, et al.
British Journal of Clinical Pharmacology (2021) Vol. 88, Iss. 5, pp. 2065-2073
Open Access | Times Cited: 73
Immunogenicity and safety of a third dose, and immune persistence of CoronaVac vaccine in healthy adults aged 18-59 years: interim results from a double-blind, randomized, placebo-controlled phase 2 clinical trial
Hongxing Pan, Qianhui Wu, Gang Zeng, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 72
Effectiveness of BNT162b2 Vaccine in Adolescents during Outbreak of SARS-CoV-2 Delta Variant Infection, Israel, 2021
Aharona Glatman‐Freedman, Yael Hershkovitz, Zalman Kaufman, et al.
Emerging infectious diseases (2021) Vol. 27, Iss. 11, pp. 2919-2922
Open Access | Times Cited: 70
Metabolic disorders, COVID-19 and vaccine-breakthrough infections
Norbert Stefan
Nature Reviews Endocrinology (2021) Vol. 18, Iss. 2, pp. 75-76
Open Access | Times Cited: 67
Immune recall improves antibody durability and breadth to SARS-CoV-2 variants
Yuezhou Chen, Pei Tong, Noah B. Whiteman, et al.
Science Immunology (2022) Vol. 7, Iss. 78
Open Access | Times Cited: 63
A Narrative Review of COVID-19 Vaccines
Barbaros Eroglu, Rina Fajri Nuwarda, Iqbal Ramzan, et al.
Vaccines (2021) Vol. 10, Iss. 1, pp. 62-62
Open Access | Times Cited: 54
SARS-CoV-2 antibodies and breakthrough infections in the Virus Watch cohort
Robert W Aldridge, Alexei Yavlinsky, Vincent Nguyen, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 54
Post COVID-19 condition of the Omicron variant of SARS-CoV-2
Shinichiro Morioka, Shinya Tsuzuki, Michiyo Suzuki, et al.
Journal of Infection and Chemotherapy (2022) Vol. 28, Iss. 11, pp. 1546-1551
Open Access | Times Cited: 52
Antibody Response to SARS-CoV-2 Vaccination in Patients following Allogeneic Hematopoietic Cell Transplantation
Alice S. Huang, Caroline Cicin‐Sain, Chloé Pasin, et al.
Transplantation and Cellular Therapy (2022) Vol. 28, Iss. 4, pp. 214.e1-214.e11
Open Access | Times Cited: 51
Humoral immune response of BBIBP COVID‐19 vaccination before and after the booster immunization
Zhangkai J. Cheng, Huimin Huang, Peiyan Zheng, et al.
Allergy (2022) Vol. 77, Iss. 8, pp. 2404-2414
Open Access | Times Cited: 48
Humoral and cellular response to COVID-19 vaccination in patients with autoimmune inflammatory rheumatic diseases under real-life conditions
Marco Krasselt, Ulf Wagner, Phuong Nguyen, et al.
Lara D. Veeken (2022) Vol. 61, Iss. SI2, pp. SI180-SI188
Open Access | Times Cited: 47
Anti-SARS-CoV-2 IgA and IgG in human milk after vaccination is dependent on vaccine type and previous SARS-CoV-2 exposure: a longitudinal study
Marta Selma‐Royo, Christine Bäuerl, Desirée Mena‐Tudela, et al.
Genome Medicine (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 47
Neutralizing antibody response against the B.1.617.2 (delta) and the B.1.1.529 (omicron) variants after a third mRNA SARS-CoV-2 vaccine dose in kidney transplant recipients
Louise Benning, Christian Morath, Marie Bartenschlager, et al.
American Journal of Transplantation (2022) Vol. 22, Iss. 7, pp. 1873-1883
Open Access | Times Cited: 46
Kinetics of the B- and T-Cell Immune Responses After 6 Months From SARS-CoV-2 mRNA Vaccination in Patients With Rheumatoid Arthritis
Chiara Farroni, Andrea Picchianti Diamanti, Alessandra Aiello, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 45
Duration of immunity following full vaccination against SARS-CoV-2: a systematic review
Isaac Yeboah Addo, Frederick Dadzie, Sylvester Reuben Okeke, et al.
Archives of Public Health (2022) Vol. 80, Iss. 1
Open Access | Times Cited: 45
Covid-19: virology, variants, and vaccines
Megan Young, Harry Crook, J. T. Scott, et al.
BMJ Medicine (2022) Vol. 1, Iss. 1, pp. e000040-e000040
Open Access | Times Cited: 43
A dual-antigen self-amplifying RNA SARS-CoV-2 vaccine induces potent humoral and cellular immune responses and protects against SARS-CoV-2 variants through T cell-mediated immunity
Séan Mc Cafferty, A.K.M. Ashiqul Haque, Aster Vandierendonck, et al.
Molecular Therapy (2022) Vol. 30, Iss. 9, pp. 2968-2983
Open Access | Times Cited: 41
A Systematic Review and Meta-Analysis of Serologic Response following Coronavirus Disease 2019 (COVID-19) Vaccination in Solid Organ Transplant Recipients
Atsushi Sakuraba, Alexander Luna, Dejan Micić
Viruses (2022) Vol. 14, Iss. 8, pp. 1822-1822
Open Access | Times Cited: 39
Risk of Vaccine Breakthrough SARS-CoV-2 Infection and Associated Factors in Healthcare Workers of Trieste Teaching Hospitals (North-Eastern Italy)
Paolo Basso, Corrado Negro, Luca Cegolon, et al.
Viruses (2022) Vol. 14, Iss. 2, pp. 336-336
Open Access | Times Cited: 38
Age and sex associations of SARS-CoV-2 antibody responses post BNT162b2 vaccination in healthcare workers: A mixed effects model across two vaccination periods
Cleo Anastassopoulou, Dimitra Antoni, Yiannis Manoussopoulos, et al.
PLoS ONE (2022) Vol. 17, Iss. 4, pp. e0266958-e0266958
Open Access | Times Cited: 38
Defending against SARS-CoV-2: The T cell perspective
Patricia Almendro-Vázquez, Rocío Laguna‐Goya, Estela Paz‐Artal
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 36

Scroll to top